Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
Study Information
Alliance Study ID: CALGB-9682
NCT Study ID (ClinicalTrials.gov): NCT00002889
Alliance Committee: Genitourinary Cancer
Disease or Cancer Type: Prostate Cancer
Alliance Study Chair: Anthony V. D'Amico, MD, PhD
Status: COMPLETED
Study Description
RATIONALE: Imaging procedures such as MRI may improve the ability to determine the response of prostate tumors to therapy.
PURPOSE: Phase II trial to study MRI results in patients with prostate cancer that has been treated with radiation therapy plus androgen suppression therapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information